Conoscenze Home Salute delle persone Conoscenze All Parere Documenti Scienza popolare Interviste Filtra Therapeutic areasCOVID-19Salute digestiva Apply Home Salute delle persone Conoscenze Safety and immunogenicity of the protein-based PHH-1V compared to BNT162b2 as a heterologous SARS-CoV-2 booster vaccine in adults vaccinated against COVID-19 Home Salute delle persone Conoscenze Preclinical evaluation of PHH-1V candidate against SARS-CoV-2 in non-human primates Home Salute delle persone Conoscenze Immunogenicity and safety in pigs of PHH-1V, a SARS-CoV-2 RBD fusion heterodimer vaccine candidate Home Salute delle persone Conoscenze Safety and immunogenicity of a recombinant protein RBD fusion heterodimer vaccine against SARS-CoV-2 Home Salute delle persone Conoscenze Humoral and cellular immune responses after 6 months of a heterologous SARS-CoV-2 booster with the protein-based PHH-1V vaccine in a phase IIb trial Home Salute delle persone Conoscenze Safety and immunogenicity of PHH-1V as booster vaccination through the Omicron era: results from a phase IIb open-label extension study up to 6 months Home Salute delle persone Conoscenze Preclinical evaluation of a COVID-19 vaccine candidate based on a recombinant RBD fusion heterodimer of SARS-CoV-2 Home Salute delle persone Conoscenze RBDCOV Talks HIPRA’s participation: In 5 minutes, what is a recombinant protein vaccine? Home Salute delle persone Conoscenze RBDCOV: The project’s origins and future endeavours Carica di più
